Therapeutic potential of antifungal plant and insect defensins.
To defend themselves against invading fungal pathogens, plants and insects largely depend on the production of a wide array of antifungal molecules, including antimicrobial peptides such as defensins. Interestingly, plant and insect defensins display antimicrobial activity not only against plant and insect pathogens but also against human fungal pathogens, including Candida spp. and Aspergillus spp. This review focuses on these defensins as novel leads for antifungal therapeutics. Their mode of action, involving interaction with fungus-specific sphingolipids, and heterologous expression, required for cost-effective production, are major assets for development of plant and insect defensins as antifungal leads. Studies evaluating their in vivo antifungal efficacy demonstrate their therapeutic potential.
Thevissen
Karin
K
Centre of Microbial and Plant Genetics, Kasteelpark Arenberg 20, B-3001 Heverlee, Belgium.
Kristensen
Hans-Henrik
HH
Thomma
Bart P H J
BP
Cammue
Bruno P A
BP
François
Isabelle E J A
IE
D000595:Amino Acid Sequence; D000818:Animals; D000935:Antifungal Agents / Q000627:therapeutic use*; D023082:Defensins / Q000096:biosynthesis / Q000737:chemistry / Q000627:therapeutic use*; D006801:Humans; D019476:Insect Proteins / Q000627:therapeutic use*; D008969:Molecular Sequence Data; D009181:Mycoses / Q000188:drug therapy; D010940:Plant Proteins / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000096:biosynthesis
D000935:Antifungal Agents; D023082:Defensins; D019476:Insect Proteins; D010940:Plant Proteins; D011994:Recombinant Proteins